DEBBY MALONEY: Open Payments
NPI 1851965925 · WASILLA, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 18 payments from 10 companies in 2025. Trend: 2023 $1,042 · 2024 $776 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $73 |
| Novo Nordisk Inc | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Radius Health, Inc. | 1 | $29 |
| PFIZER INC. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| ViiV Healthcare Company | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: CAPLYTA, AIRSUPRA, Wegovy, UBRELVY, PONVORY, Tymlos, NURTEC ODT, Ozempic.
Industry payments across AK — which companies pay providers there.
